Welcome to our dedicated page for Veeva Sys news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Sys stock.
Veeva Systems Inc. (NYSE: VEEV) is a cloud software company focused on the global life sciences industry, and its news flow reflects activity across commercial, R&D, quality, and corporate initiatives. Company announcements frequently highlight new product capabilities in its industry cloud for life sciences, including developments in Veeva AI, Vault CRM, Veeva Development Cloud, Veeva Quality Cloud, and solutions such as Veeva Environmental Monitoring and Veeva Basics.
Investors and industry professionals following VEEV news can see updates on strategic partnerships with major life sciences companies, such as long-term enterprise agreements and expanded use of Vault CRM by large pharmaceutical and biopharmaceutical organizations. Veeva also issues releases on its work with emerging biotechs, including adoption of Veeva Basics to standardize operations across clinical, regulatory, and quality.
Veeva’s news includes information on AI-driven capabilities like Veeva AI Agents for Vault CRM and PromoMats, covering agents such as Free Text Agent, Voice Agent, Pre-call Agent, Quick Check Agent, and Content Agent. These updates describe how the company embeds industry-specific AI into its applications to support productivity, compliance, and customer engagement in life sciences.
In addition, Veeva regularly publishes earnings results, financial outlooks, and capital allocation decisions, such as the authorization of a share repurchase program reported in an 8-K filing. The company also announces participation in investor conferences and provides details on its role as a Public Benefit Corporation. This news page aggregates these releases so readers can track product milestones, customer agreements, AI developments, financial updates, and corporate governance disclosures related to VEEV.
Veeva Systems (NYSE: VEEV) announced that Bavarian Nordic is utilizing its Veeva CRM and Veeva Vault PromoMats for a digital product launch across the U.S. and Europe, enhancing their digital engagement capabilities. Bavarian Nordic, focused on vaccines for infectious diseases, chose Veeva to meet aggressive launch timelines and support global growth. This partnership allows for effective HCP interactions through digital channels, ensuring compliance and timely content delivery, further solidifying Veeva's role in driving digital transformation within the life sciences sector.
Veeva Systems has launched MyVeeva for Doctors, a mobile app designed to streamline healthcare professionals' access to key resources from life sciences companies. This solution aims to facilitate connections between healthcare providers and pharmaceutical firms, offering essential services like product samples and copay cards in one place. Early adopters include major companies such as GSK, Pfizer, and Sanofi, with the app currently available in select markets including the US and UK. The initiative is intended to enhance patient care by improving the efficiency of healthcare professionals.
Veeva Systems (NYSE: VEEV) has launched MyVeeva for Doctors, a mobile app aimed at enhancing healthcare professionals' access to resources from pharmaceutical and biotech companies. This initiative aims to streamline interactions between healthcare providers (HCPs) and life sciences, allowing HCPs to easily connect with key contacts and access information. Initial partnerships include major companies like Boehringer Ingelheim, GSK, and Pfizer. The app is currently available in select markets including the U.S. and U.K., with plans for expansion in 2021.
Veeva Systems (NYSE: VEEV) has announced keynote speakers for the upcoming 2020 Veeva Medical Device & Diagnostics Summit Online, featuring industry leaders from Boston Scientific, Illumina, Johnson & Johnson, and QIAGEN. The event aims to address the modernization of processes and compliance in the medical device sector, with over 1,000 professionals expected to attend. Key sessions will include insights on clinical data unification from Alcon and RIM transformation by Baxter Healthcare. The summit will take place on Oct. 28-29, 2020.
Veeva Systems (NYSE: VEEV) announced that CANbridge Pharmaceuticals has adopted Veeva Vault QualityDocs to enhance its global clinical trials. This cloud-based solution streamlines document management, ensuring compliance and audit readiness. CANbridge's previous paper-based system was resource-intensive, and the switch to Vault QualityDocs is expected to save time and improve quality assurance in their clinical studies. The initiative aims to facilitate knowledge sharing and accelerate the delivery of life-saving therapies worldwide.
Veeva Systems (NYSE: VEEV) announced that Exact Sciences has chosen the Veeva Vault Clinical Suite to enhance its clinical study processes. This suite includes Vault CDMS, Vault CTMS, and Vault eTMF which will enable Exact Sciences to manage clinical data, trials, and compliance more efficiently. The partnership aims to accelerate the development of innovative cancer diagnostics, ensuring readiness for EU IVDR and MDR regulations. Exact Sciences expects to streamline its clinical studies and improve operational efficiency through this collaboration.
Veeva Systems (NYSE: VEEV) reports growing adoption of its Vault Quality Suite, with over 300 organizations, including 13 of the top 20 global pharmaceutical companies, utilizing its applications for quality management. Key features include streamlined processes, improved collaboration, and enhanced visibility for life sciences firms. The suite supports various functionalities such as Vault Training and Vault Product Surveillance. Veeva's ongoing innovations aim to modernize quality management across industries, emphasizing the demand for unified solutions in the ever-evolving healthcare sector.
Veeva Systems (NYSE: VEEV) announced that Roche has selected its Veeva Development Cloud applications to enhance clinical, regulatory, and quality processes globally. This transition aims to improve efficiency and compliance within Roche's product lifecycle. The collaboration emphasizes Roche's priority to accelerate drug development. Veeva offers various applications including Vault Clinical, Vault RIM, and Vault Quality to streamline operations.
Veeva Systems (NYSE: VEEV) announces a growing adoption of its Veeva Vault CDMS for clinical data management by numerous biotechs and a top 20 pharmaceutical company. Vault CDMS has been utilized in over 100 trials across various phases and therapeutic areas, enabling faster study initiation. The platform facilitates the creation of study databases in under four weeks and allows for mid-study amendments without downtime. Notable companies like Eli Lilly and Alcon are leveraging Vault CDMS for enhanced data management efficiency.
Veeva Systems (NYSE: VEEV) has launched two applications on the Veeva Clinical Network to streamline clinical trial processes. Veeva Site Connect enables automated information sharing between sponsors and clinical sites, enhancing efficiency in document exchange and site engagement. Veeva eConsent digitizes the patient consent process, improving transparency and compliance. Both solutions aim to accelerate patient-centric trials. The launch responds to growing needs for paperless solutions in the industry and is part of Veeva's commitment to innovation.